October 23rd 2023
Celltrion’s Zymfentra is subcutaneous version of infliximab.
CMS Proposes Actions to Lower Prescription Drug Costs: 4 Things to Know
December 12th 2018In an effort to lower prescription drug prices, CMS unveiled proposed polices for 2020 to strengthen and modernize the Medicare Part C and D programs. Here’s a closer look at what CMS’ provisions entail and how they help accomplish the Administration’s four strategies.
Read More
New Reimbursement May Level Playing Field for Biosimilars
May 21st 2018The new Bipartisan Budget Act of 2018 (to be in effect on January 2019) institute new reimbursement guidelines for biosimilars under the Medicare coverage gap discount program that remove disincentives for biosimilar uptake and level the playing field for the future market place.
Read More